During the past decade, SocraTec R&D GmbH conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SocraTec R&D GmbH" #1 sponsor was "SocraTec R&D GmbH" with 7 trials, followed by "Bayer" with 3 trials sponsored, "Fresenius Kabi" with 2 trials sponsored, "Vakzine Projekt Management GmbH" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SocraTec R&D GmbH" #1 collaborator was "SocraMetrics GmbH" with 8 trials as a collaborator, "FGK Clinical Research GmbH" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Glatt Pharmaceutical Services GmbH & Co. KG" with 1 trials as a collaborator and "SocraTec R&D GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "SocraTec R&D GmbH" are "Bioequivalence" (4 trials), "Comparative Bioavailability" (2 trials), "Infection, Respiratory Tract" (2 trials), "Malnutrition" (2 trials) and "Bioavailability, Therapeutical Indication Not Studied" (1 trials). Many other conditions were trialed in "SocraTec R&D GmbH" in a lesser frequency.

Most popular intervention types in "SocraTec R&D GmbH" are "Drug" (14 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "High caloric, high protein ONS" (2 trials), "VPM1002" (2 trials), "40 mg Esomeprazole Mepha (Mepha Ltd., Switzerland)" (1 trials) and "BI 685509" (1 trials). Other intervention names were less common.

The vast majority of trials in "SocraTec R&D GmbH" are 12 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "SocraTec R&D GmbH". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in SocraTec R&D GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SocraTec R&D GmbH, 12 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".